Clinical trials
Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 12 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
| Completed | 20 |
| Recruiting | 19 |
| Terminated | 11 |
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Hoffmann-La Roche | 5 |
| Novartis Pharmaceuticals | 5 |
| Pfizer | 5 |
| Eli Lilly and Company | 3 |
| Janssen Research & Development, LLC | 3 |
| Yuhan Corporation | 3 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Mural Oncology, Inc | 2 |
| National Cancer Center, Korea | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 76 |
| Lung Neoplasms | 16 |
| Colorectal Neoplasms | 13 |
| Neoplasms | 13 |
| Squamous Cell Carcinoma of Head and Neck | 13 |
| Neoplasm Metastasis | 12 |
| Breast Neoplasms | 11 |
| Head and Neck Neoplasms | 10 |
| Stomach Neoplasms | 10 |
| Carcinoma, Renal Cell | 7 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.